JAK Inhibitors in Refractory Idiopathic Uveitis or Associated With Immune-Mediated Inflammatory Diseases: A Multicenter Case Series and Literature Review of Real-World Clinical Practice.
PURPOSE To assess the effectiveness and safety of Janus kinase inhibitors (JAKi) in patients with idiopathic or immune-mediated inflammatory diseases (IMID)-associated non-infectious uveitis (NIU) refractory to conventional therapy, and to synthesize available observational evidence. METHODS We conducted a multicente...